Merck (MRK) is a leading global healthcare company recognized for its groundbreaking pharmaceutical products and vaccines.
We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...
Young, a music teacher, met the King at UCLH last year while taking part in the first personalised trial of the mRNA vaccine for melanoma - the most dangerous form of skin cancer. He had invited the ...
A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.
We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other ...
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
A cancer vaccine generated using the cells left over after tumour removal surgery could help to keep patients from ...
The U.K. is continuing to shape up regulation, adding reform of its accelerated drug approval process and its draft guidance on personalized mRNA cancer vaccines to new clinical trial regulations that ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results